Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2.
Primarily an infection of the lower respiratory tract, it is now well known to cause multisystem …

The advent of bone marrow transplant has opened doors to a different approach and offered
a new treatment modality for various hematopoietic stem-cell-related disorders. Since the …

Thrombotic complications from COVID-19 are now well known and contribute to significant
morbidity and mortality. Different variants confer varying risks of thrombotic complications …

Background Direct oral anticoagulants (DOACs) are effective for the management of
thromboembolic disorders. However, bleeding remains a major concern in cirrhotic patients …

Jaw cysts represent a great matter of interest in oral and maxillofacial surgery. Jaw cyst
surgery is a common intervention in oral surgery but, in the case of a multidisciplinary …

Direct oral anticoagulants (DOACs) are recommended for the prevention of
thromboembolism in patients with atrial fibrillation (AF), and are now preferred over vitamin …

A major advancement in the field of medicine has been the introduction and usage of direct
oral anticoagulants (DOACs) such as dabigatran (Pradaxa), apixaban (Eliquis), and …

It is challenging to stop bleeding effectively in patients treated with heparin which leads to
enhanced risk of uncontrolled bleeding during operation. Herein, we report an easy-to-use …

Aims Bleeding events are a well-known complication of oral anticoagulant (OAC) use in
patients with atrial fibrillation (AF). While these are undesirable, bleedings could have a …

Background Anticoagulants increase the risk of cardiac tamponade in patients with
pericardial effusion (PE). Therefore, inappropriate administration of them in the presence of …